Rtw Investments, LP Sage Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.23 Billion
- Q1 2024
A detailed history of Rtw Investments, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 5,480,577 shares of SAGE stock, worth $59.3 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
5,480,577
Previous 5,197,019
5.46%
Holding current value
$59.3 Million
Previous $113 Million
8.8%
% of portfolio
1.65%
Previous 1.85%
Shares
4 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$62.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52.9 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$51.4 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$48.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.47MShares$48.3 Million1.31% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $643M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...